Condensed Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash Flows From Operating Activities:
Net loss	$ (3,336,435)	$ (833,545)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	21,875	6,661
Share-based compensation	512,988	0
Changes in assets and liabilities:
Accounts receivable	(4,396)
Inventories	(27,075)	(131,192)
Prepaid expenses and other current assets	(63,982)	16,853
Accounts payable	196,750	24,100
Deferred and accrued officer compensation	0	26,000
Accrued liabilities and other	8,139	57,414
Net cash used in operating activities	(2,692,136)	(833,709)
Cash Flows From Investing Activities:
Capital expenditures for property and equipment	(14,225)	(35,103)
Investment in patents and trademarks	(120,070)	0
Net cash used in investing activities	(134,295)	(35,103)
Cash Flows From Financing Activities:
Sale of common stock and warrants	13,683,222	3,767,800
Offering costs paid	(1,542,436)	(70,084)
Payment of notes payable	(39,435)	0
Net cash provided by financing activities	12,101,351	3,697,716
Net increase in cash and cash equivalents	9,274,920	2,828,904
Cash, beginning of period	3,083,976	255,072
Cash, end of period	12,358,896	3,083,976
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Interest paid	1,304	0
Non-cash investing and financing activities:
Prepaid insurance financed with note payable	39,435	0
Issuance costs relating to warrants issued to private offering selling agent	$ 664,427	$ 0